75 related articles for article (PubMed ID: 2241403)
21. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
22. [Intravenous streptokinase in acute myocardial infarction. A Mexican multicentric study].
Martínez Ríos MA; Gil M; Ojeda JL; Galante J; Fernández Vázquez F; Aguilar J; Baena H; Bojorquez R; Durán P; Leyva JL
Arch Inst Cardiol Mex; 1988; 58(6):511-5. PubMed ID: 3245721
[TBL] [Abstract][Full Text] [Related]
23. Rapid infusion of streptokinase standard dose in acute myocardial infarction is followed by a higher rate of coronary reperfusion than standard protocol.
Tatu-Chiţoiu G; Orha I; Teodorescu C; Flueraşu A; Serban L; Bumbu A
Rom J Intern Med; 1997; 35(1-4):47-54. PubMed ID: 9562652
[TBL] [Abstract][Full Text] [Related]
24. [Intravenous streptokinase treatment of acute myocardial infarction. I. Effect of the treatment on the course of infarction and the patency of the artery supplying the infarction area].
Aleksandrow W; Borkowski P; Iwanowski L; Kwiatkowski W; Roszczyk R; Ostrowska B
Kardiol Pol; 1989; 32(4):194-201. PubMed ID: 2622109
[TBL] [Abstract][Full Text] [Related]
25. [The Italian Group for the Study of Streptokinase in Myocardial Infarct: Evaluation of the enzymatic curve of creatine kinase].
Bossi M; Matta F
G Ital Cardiol; 1987 Jan; 17(1):45-56. PubMed ID: 3552838
[TBL] [Abstract][Full Text] [Related]
26. Early operative intervention after thrombolytic therapy for acute myocardial infarction.
Wellons HA; Schneider JA; Mikell FL; Moses HW; Dove JT; Batchelder JE; Taylor GJ
J Vasc Surg; 1985 Jan; 2(1):186-91. PubMed ID: 3965751
[TBL] [Abstract][Full Text] [Related]
27. [Results of the Austrian myocardial infarction study on the effects of streptokinase (author's transl)].
Benda L; Haider M; Ambrosch F
Wien Klin Wochenschr; 1977 Dec; 89(23):779-83. PubMed ID: 339553
[TBL] [Abstract][Full Text] [Related]
28. Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase.
Lew AS; Hod H; Cercek B; Shah PK; Ganz W
Am J Cardiol; 1987 Jan; 59(1):1-5. PubMed ID: 3812217
[TBL] [Abstract][Full Text] [Related]
29. [The treatment of myocardial infarct with streptokinase].
Valere PE; Tricot R
Ann Anesthesiol Fr; 1978; 19(8):727-33. PubMed ID: 31117
[TBL] [Abstract][Full Text] [Related]
30. Thrombolytic therapy followed by early revascularization for acute myocardial infarction.
Sutton JM; Taylor GJ; Mikell FL; Moses HW; Korsmeyer C; Dove JT; Batchelder JE; Wellons HA; Schneider JA
Am J Cardiol; 1986 Jun; 57(15):1227-31. PubMed ID: 3717018
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of the effect of intravenous administration of streptodecase on the extent of the damage in myocardial infarction].
Ramazanov DM; Rustamov ChI; Gel'fgat EB
Klin Med (Mosk); 1990 Jul; 68(7):63-6. PubMed ID: 2232652
[TBL] [Abstract][Full Text] [Related]
32. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group.
Lancet; 1993 Sep; 342(8874):767-72. PubMed ID: 8103875
[TBL] [Abstract][Full Text] [Related]
33. Analysis of reported randomized trials of streptokinase therapy for acute myocardial infarction in the 1980s.
Patel B; Kloner RA
Am J Cardiol; 1987 Mar; 59(6):501-4. PubMed ID: 3548298
[TBL] [Abstract][Full Text] [Related]
34. [The effect of intravenous streptokinase on selected echocardiographic and clinical parameters of patients followed up for 2 years after myocardial infarction].
Poprawski K; Piszczek I; Smukowski T; Ochotny R; Błaszyk K; Paradowski S
Pol Arch Med Wewn; 1991 Jan; 85(1):27-34. PubMed ID: 2038573
[TBL] [Abstract][Full Text] [Related]
35. [Henoch-Schönlein purpura following treatment with streptokinase].
Stam F; Stehouwer CD
Ned Tijdschr Geneeskd; 1992 Nov; 136(47):2336-8. PubMed ID: 1461306
[TBL] [Abstract][Full Text] [Related]
36. Intravenous streptokinase in acute myocardial infarction.
N Engl J Med; 1986 Nov; 315(21):1356-7. PubMed ID: 3773960
[No Abstract] [Full Text] [Related]
37. The primary care physician and thrombolytic therapy for acute myocardial infarction: comparison of intravenous streptokinase in community hospitals and the tertiary referral center.
Taylor GJ; Song A; Moses HW; Koester DL; Mikell FL; Dove JT; Katholi RE; Wellons HA; Schneider JA
J Am Board Fam Pract; 1990; 3(1):1-6. PubMed ID: 2305636
[TBL] [Abstract][Full Text] [Related]
38. Effect of streptokinase on reperfusion after acute myocardial infarction and its complications: an ex-post facto study.
Taheri L; Boroujeni AZ; Kargar Jahromi M; Charkhandaz M; Hojat M
Glob J Health Sci; 2015 Jan; 7(4):184-9. PubMed ID: 25946921
[TBL] [Abstract][Full Text] [Related]
39. Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
Betancourt BY; Marrero-Miragaya MA; Jiménez-López G; Valenzuela-Silva C; García-Iglesias E; Hernández-Bernal F; Debesa-García F; González-López T; Alvarez-Falcón L; López-Saura PA;
BMC Clin Pharmacol; 2005 Nov; 5():5. PubMed ID: 16262910
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous leukocytoclastic vasculitis in relation to streptokinase.
Bindels AJ; See TL; Peters WG
Neth J Med; 1992 Feb; 40(1-2):76-9. PubMed ID: 1579189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
